Cargando…

Aspirin Inhibits Carcinogenesis of Intestinal Mucosal Cells in UC Mice Through Inhibiting IL-6/JAK/STAT3 Signaling Pathway and Modulating Apoptosis and Proliferation

BACKGROUND: Colorectal cancer is related to ulcerative colitis. This study aimed to investigate the effects of aspirin on non-specific inflammation developing into cancer. METHODS: Ulcerative colitis model was generated by administrating azoxymethane/dextran sulfate sodium to mice. Weight, tumor siz...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yingying, Sun, Liying, Li, Dongyue, Yin, Xunhai, Shang, Guoyin, Diao, Tiantian, Shi, Lijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish Society of Gastroenterology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533073/
https://www.ncbi.nlm.nih.gov/pubmed/35946886
http://dx.doi.org/10.5152/tjg.2022.21855
_version_ 1784802263563239424
author Chen, Yingying
Sun, Liying
Li, Dongyue
Yin, Xunhai
Shang, Guoyin
Diao, Tiantian
Shi, Lijun
author_facet Chen, Yingying
Sun, Liying
Li, Dongyue
Yin, Xunhai
Shang, Guoyin
Diao, Tiantian
Shi, Lijun
author_sort Chen, Yingying
collection PubMed
description BACKGROUND: Colorectal cancer is related to ulcerative colitis. This study aimed to investigate the effects of aspirin on non-specific inflammation developing into cancer. METHODS: Ulcerative colitis model was generated by administrating azoxymethane/dextran sulfate sodium to mice. Weight, tumor size/amount, and intestinal mucositis scores were analyzed. Inflammatory cell infiltration and atypical hyperplasia were determined with hematoxylin–eosin staining. Immunohistochemical assay was used to detect the proliferating cell nuclear antigen. Interleukin-6 and interleukin-10 were detected using enzyme-linked immunosorbent assay. Signal transducer and activator of transcription 3, phosphorylated-STAT3, cyclin D1, and suppressor of cytokine signaling 3 were examined with western blotting. RESULTS: Aspirin remarkably decreased tumor size/amount compared to those of the ulcerative colitis model group (P < .05). Interleukin-6 was increased and interleukin-10 was decreased in mice of ulcerative colitis model group compared with the control group (P < .05). Aspirin markedly reduced interleukin-6 and enhanced interleukin-10 compared to the ulcerative colitis model group (P < .05) induced Azoxymethane/dextran sulfate sodium inflammation (3 weeks) and atypical hyperplasia (8 weeks). Aspirin predominantly inhibited the “inflammation–atypical hyperplasia–cancer” process and alleviated inflammatory cell infiltration of mice in the ulcerative colitis model group. Aspirin promoted apoptosis and alleviated proliferating cell nuclear antigen of atypical hyperplastic intestinal mucosal cells at 8 weeks post-modeling. The expression of phosphorylated-STAT3, signal transducer and activator of transcription 3, cyclin D1, and suppressor of cytokine signaling 3 was significantly increased in mice of ulcerative colitis model group compared to the control group (P < .05). Aspirin remarkably decreased phosphorylated-STAT3, signal transducer and activator of transcription, and cyclin D1 expression compared with ulcerative colitis model group (P < .05). CONCLUSION: Aspirin inhibited carcinogenesis of intestinal mucosal cells in the ulcerative colitis model by inhibiting the interleukin-6/Janus kinase/signal transducer and activator of transcription 3 signaling pathway and promoted apoptosis, thereby suppressing proliferation.
format Online
Article
Text
id pubmed-9533073
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Turkish Society of Gastroenterology
record_format MEDLINE/PubMed
spelling pubmed-95330732022-10-17 Aspirin Inhibits Carcinogenesis of Intestinal Mucosal Cells in UC Mice Through Inhibiting IL-6/JAK/STAT3 Signaling Pathway and Modulating Apoptosis and Proliferation Chen, Yingying Sun, Liying Li, Dongyue Yin, Xunhai Shang, Guoyin Diao, Tiantian Shi, Lijun Turk J Gastroenterol Original Article BACKGROUND: Colorectal cancer is related to ulcerative colitis. This study aimed to investigate the effects of aspirin on non-specific inflammation developing into cancer. METHODS: Ulcerative colitis model was generated by administrating azoxymethane/dextran sulfate sodium to mice. Weight, tumor size/amount, and intestinal mucositis scores were analyzed. Inflammatory cell infiltration and atypical hyperplasia were determined with hematoxylin–eosin staining. Immunohistochemical assay was used to detect the proliferating cell nuclear antigen. Interleukin-6 and interleukin-10 were detected using enzyme-linked immunosorbent assay. Signal transducer and activator of transcription 3, phosphorylated-STAT3, cyclin D1, and suppressor of cytokine signaling 3 were examined with western blotting. RESULTS: Aspirin remarkably decreased tumor size/amount compared to those of the ulcerative colitis model group (P < .05). Interleukin-6 was increased and interleukin-10 was decreased in mice of ulcerative colitis model group compared with the control group (P < .05). Aspirin markedly reduced interleukin-6 and enhanced interleukin-10 compared to the ulcerative colitis model group (P < .05) induced Azoxymethane/dextran sulfate sodium inflammation (3 weeks) and atypical hyperplasia (8 weeks). Aspirin predominantly inhibited the “inflammation–atypical hyperplasia–cancer” process and alleviated inflammatory cell infiltration of mice in the ulcerative colitis model group. Aspirin promoted apoptosis and alleviated proliferating cell nuclear antigen of atypical hyperplastic intestinal mucosal cells at 8 weeks post-modeling. The expression of phosphorylated-STAT3, signal transducer and activator of transcription 3, cyclin D1, and suppressor of cytokine signaling 3 was significantly increased in mice of ulcerative colitis model group compared to the control group (P < .05). Aspirin remarkably decreased phosphorylated-STAT3, signal transducer and activator of transcription, and cyclin D1 expression compared with ulcerative colitis model group (P < .05). CONCLUSION: Aspirin inhibited carcinogenesis of intestinal mucosal cells in the ulcerative colitis model by inhibiting the interleukin-6/Janus kinase/signal transducer and activator of transcription 3 signaling pathway and promoted apoptosis, thereby suppressing proliferation. Turkish Society of Gastroenterology 2022-09-01 /pmc/articles/PMC9533073/ /pubmed/35946886 http://dx.doi.org/10.5152/tjg.2022.21855 Text en © Copyright 2022 authors https://creativecommons.org/licenses/by/4.0/ Content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Original Article
Chen, Yingying
Sun, Liying
Li, Dongyue
Yin, Xunhai
Shang, Guoyin
Diao, Tiantian
Shi, Lijun
Aspirin Inhibits Carcinogenesis of Intestinal Mucosal Cells in UC Mice Through Inhibiting IL-6/JAK/STAT3 Signaling Pathway and Modulating Apoptosis and Proliferation
title Aspirin Inhibits Carcinogenesis of Intestinal Mucosal Cells in UC Mice Through Inhibiting IL-6/JAK/STAT3 Signaling Pathway and Modulating Apoptosis and Proliferation
title_full Aspirin Inhibits Carcinogenesis of Intestinal Mucosal Cells in UC Mice Through Inhibiting IL-6/JAK/STAT3 Signaling Pathway and Modulating Apoptosis and Proliferation
title_fullStr Aspirin Inhibits Carcinogenesis of Intestinal Mucosal Cells in UC Mice Through Inhibiting IL-6/JAK/STAT3 Signaling Pathway and Modulating Apoptosis and Proliferation
title_full_unstemmed Aspirin Inhibits Carcinogenesis of Intestinal Mucosal Cells in UC Mice Through Inhibiting IL-6/JAK/STAT3 Signaling Pathway and Modulating Apoptosis and Proliferation
title_short Aspirin Inhibits Carcinogenesis of Intestinal Mucosal Cells in UC Mice Through Inhibiting IL-6/JAK/STAT3 Signaling Pathway and Modulating Apoptosis and Proliferation
title_sort aspirin inhibits carcinogenesis of intestinal mucosal cells in uc mice through inhibiting il-6/jak/stat3 signaling pathway and modulating apoptosis and proliferation
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533073/
https://www.ncbi.nlm.nih.gov/pubmed/35946886
http://dx.doi.org/10.5152/tjg.2022.21855
work_keys_str_mv AT chenyingying aspirininhibitscarcinogenesisofintestinalmucosalcellsinucmicethroughinhibitingil6jakstat3signalingpathwayandmodulatingapoptosisandproliferation
AT sunliying aspirininhibitscarcinogenesisofintestinalmucosalcellsinucmicethroughinhibitingil6jakstat3signalingpathwayandmodulatingapoptosisandproliferation
AT lidongyue aspirininhibitscarcinogenesisofintestinalmucosalcellsinucmicethroughinhibitingil6jakstat3signalingpathwayandmodulatingapoptosisandproliferation
AT yinxunhai aspirininhibitscarcinogenesisofintestinalmucosalcellsinucmicethroughinhibitingil6jakstat3signalingpathwayandmodulatingapoptosisandproliferation
AT shangguoyin aspirininhibitscarcinogenesisofintestinalmucosalcellsinucmicethroughinhibitingil6jakstat3signalingpathwayandmodulatingapoptosisandproliferation
AT diaotiantian aspirininhibitscarcinogenesisofintestinalmucosalcellsinucmicethroughinhibitingil6jakstat3signalingpathwayandmodulatingapoptosisandproliferation
AT shilijun aspirininhibitscarcinogenesisofintestinalmucosalcellsinucmicethroughinhibitingil6jakstat3signalingpathwayandmodulatingapoptosisandproliferation